AAAAAA

   
Results: 1-17 |
Results: 17
EXPRESSION OF PIG ENDOGENOUS RETROVIRUS BY PRIMARY PORCINE ENDOTHELIAL-CELLS AND INFECTION OF HUMAN-CELLS
Authors: MARTIN U KIESSIG V BLUSCH JH HAVERICH A VONDERHELM K HERDEN T STEINHOFF G
Citation: U. Martin et al., EXPRESSION OF PIG ENDOGENOUS RETROVIRUS BY PRIMARY PORCINE ENDOTHELIAL-CELLS AND INFECTION OF HUMAN-CELLS, Lancet, 352(9129), 1998, pp. 692-694
CLEAVAGE OF THE COMPLEMENT-SYSTEM C3 COMPONENT BY HIV-1 PROTEINASE
Authors: KISSELEV AF MENTELE R VONDERHELM K
Citation: Af. Kisselev et al., CLEAVAGE OF THE COMPLEMENT-SYSTEM C3 COMPONENT BY HIV-1 PROTEINASE, Biological chemistry, 378(5), 1997, pp. 439-442
RETROVIRAL PROTEASES - STRUCTURE, FUNCTION AND INHIBITION FROM A NON-ANTICIPATED VIRAL ENZYME TO THE TARGET OF A MOST PROMISING HIV THERAPY
Authors: VONDERHELM K
Citation: K. Vonderhelm, RETROVIRAL PROTEASES - STRUCTURE, FUNCTION AND INHIBITION FROM A NON-ANTICIPATED VIRAL ENZYME TO THE TARGET OF A MOST PROMISING HIV THERAPY, Biological chemistry, 377(12), 1996, pp. 765-774
SEROEPIDEMIOLOGY OF THE HUMAN T-CELL LEUKAEMIA LYMPHOMA VIRUSES IN EUROPE/
Authors: GOUBAU P WANTZIN P GESSAIN A JEANNEL D COSTE J PAULI G VONDERHELM K BERTAZZONI U CASOLI C DEROSSI A DELMISTRO A WICKS R GABUTTI G SARACCO A VARNIER O HUISMAN J AVILLEZ F SORIANO V HATZAKIS A GURSEVITCH V HORAL P ANDERSSON S BREWER J BRENNAN M MORTIMER P TOSSWILL J NOONE A PATRICK H WEISS R WEBER J TAYLOR G
Citation: P. Goubau et al., SEROEPIDEMIOLOGY OF THE HUMAN T-CELL LEUKAEMIA LYMPHOMA VIRUSES IN EUROPE/, Journal of acquired immune deficiency syndromes and human retrovirology, 13(1), 1996, pp. 68-77
RISK OF HTLV-I TRANSMISSION BY COAGULATION-FACTOR CONCENTRATES - SEROPREVALENCE IN GERMAN HEMOPHILIACS
Authors: UNKRIG CJ OLDENBURG J FISCHER JC BRACKMANN HH VONDERHELM K VETTER H
Citation: Cj. Unkrig et al., RISK OF HTLV-I TRANSMISSION BY COAGULATION-FACTOR CONCENTRATES - SEROPREVALENCE IN GERMAN HEMOPHILIACS, Blood, 88(10), 1996, pp. 3118-3118
THE HTLV-PROTEINASE - IN CONTRAST TO THE HIV PROTEINASE - DOES NOT SIGNIFICANTLY AFFECT HOST-CELL PROTEINS AND STRUCTURES
Authors: KISSELEV A HUTTERMANN C SHOEMAN R SEELMEIR S VONDERHELM K
Citation: A. Kisselev et al., THE HTLV-PROTEINASE - IN CONTRAST TO THE HIV PROTEINASE - DOES NOT SIGNIFICANTLY AFFECT HOST-CELL PROTEINS AND STRUCTURES, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 48-48
RESISTANCE OF HIV TYPE-1 TO PROTEINASE-INHIBITOR RO-31-8959
Authors: EBERLE J BECHOWSKY B ROSE D HAUSER U VONDERHELM K GURTLER L NITSCHKO H
Citation: J. Eberle et al., RESISTANCE OF HIV TYPE-1 TO PROTEINASE-INHIBITOR RO-31-8959, AIDS research and human retroviruses, 11(6), 1995, pp. 671-676
NON-MATURED, NONINFECTIOUS HIV PARTICLES KILL CD4-POSITIVE LYMPHOCYTES
Authors: NITSCHKO HM GELDERBLOM HR KORN A VONDERHELM K
Citation: Hm. Nitschko et al., NON-MATURED, NONINFECTIOUS HIV PARTICLES KILL CD4-POSITIVE LYMPHOCYTES, AIDS research and human retroviruses, 11, 1995, pp. 81-81
RISK OF HTLVI TRANSMISSION BY COAGULATION-FACTOR CONCENTRATES - SEROPREVALENCE IN GERMAN HEMOPHILIACS
Authors: UNKRIG CJ OLDENBURG J EFFENBERGER W FISCHER JC SOMMERFELD A BRACKMANN HH VONDERHELM K
Citation: Cj. Unkrig et al., RISK OF HTLVI TRANSMISSION BY COAGULATION-FACTOR CONCENTRATES - SEROPREVALENCE IN GERMAN HEMOPHILIACS, Thrombosis and haemostasis, 73(6), 1995, pp. 1026-1026
IN-VIVO PROCESSING OF PR160(GAG-POL) FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) IN ACUTELY INFECTED, CULTURED HUMAN T-LYMPHOCYTES
Authors: LINDHOFER H VONDERHELM K NITSCHKO H
Citation: H. Lindhofer et al., IN-VIVO PROCESSING OF PR160(GAG-POL) FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) IN ACUTELY INFECTED, CULTURED HUMAN T-LYMPHOCYTES, Virology, 214(2), 1995, pp. 624-627
LONG-TERM TREATMENT OF HIV-INFECTED MT-4 CELLS IN CULTURE WITH HIV PROTEINASE-INHIBITOR RO-31-8959 LEADS TO COMPLETE CURE OF INFECTION
Authors: NITSCHKO H LINDHOFER H SCHATZL H EBERLE J DEBY G KRANZ B VONDERHELM K
Citation: H. Nitschko et al., LONG-TERM TREATMENT OF HIV-INFECTED MT-4 CELLS IN CULTURE WITH HIV PROTEINASE-INHIBITOR RO-31-8959 LEADS TO COMPLETE CURE OF INFECTION, Antiviral chemistry & chemotherapy, 5(4), 1994, pp. 236-242
PREVALENCE OF HTLV-I II INFECTIONS IN GERMANY
Authors: SCHATZL H KLEEFF J ROSE D VONDERHELM K
Citation: H. Schatzl et al., PREVALENCE OF HTLV-I II INFECTIONS IN GERMANY, AIDS research and human retroviruses, 10(4), 1994, pp. 493-493
CLEAVAGE OF HUMAN SERPINS BY HIV-1 PROTEINASE
Authors: KISSELEV AF MENTELE R SCHULZE A VONDERHELM K
Citation: Af. Kisselev et al., CLEAVAGE OF HUMAN SERPINS BY HIV-1 PROTEINASE, Journal of cellular biochemistry, 1994, pp. 168-168
PROTEOLYTIC ACTIVITY OF THE HTLV PROTEINASE
Authors: VONDERHELM K KISSELEV A SEELMEIR S
Citation: K. Vonderhelm et al., PROTEOLYTIC ACTIVITY OF THE HTLV PROTEINASE, Journal of cellular biochemistry, 1994, pp. 175-175
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE IS RAPIDLY AND EFFICIENTLY INACTIVATED IN HUMAN PLASMA BY ALPHA(2)-MACROGLOBULIN
Authors: KISSELEV AF VONDERHELM K
Citation: Af. Kisselev et K. Vonderhelm, HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE IS RAPIDLY AND EFFICIENTLY INACTIVATED IN HUMAN PLASMA BY ALPHA(2)-MACROGLOBULIN, Biological chemistry Hoppe-Seyler, 375(10), 1994, pp. 711-714
PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS-INFECTIONS IN GERMANY
Authors: SCHATZL H SCHWARZFISCHER G ROSE D GATHOF B WEISE W DEINHARDT F VONDERHELM K
Citation: H. Schatzl et al., PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS-INFECTIONS IN GERMANY, Journal of medical virology, 43(2), 1994, pp. 159-160
THE SUKHUMI PRIMATE MONKEY MODEL FOR VIRAL LYMPHOMOGENESIS - HIGH-INCIDENCE OF LYMPHOMAS WITH PRESENCE OF STLV-I AND EBV-LIKE VIRUS
Authors: SCHATZL H TSCHIKOBAVA M ROSE D VOEVODIN A NITSCHKO H SIEGER E BUSCH U VONDERHELM K LAPIN B
Citation: H. Schatzl et al., THE SUKHUMI PRIMATE MONKEY MODEL FOR VIRAL LYMPHOMOGENESIS - HIGH-INCIDENCE OF LYMPHOMAS WITH PRESENCE OF STLV-I AND EBV-LIKE VIRUS, Leukemia, 7, 1993, pp. 190000086-190000092
Risultati: 1-17 |